Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Nov 14;15(12):2091-2092.
doi: 10.1021/acsmedchemlett.4c00535. eCollection 2024 Dec 12.

Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes Mellitus

Ram W Sabnis  1
Affiliations
Editorial

Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes Mellitus

Ram W Sabnis. ACS Med Chem Lett. .

Abstract

Provided herein are novel GIPR antagonists, pharmaceutical compositions, use of such compounds in treating obesity and type 2 diabetes mellitus and processes for preparing such compounds.

PubMed Disclaimer

Conflict of interest statement

The author declares no competing financial interest.

Similar articles

See all similar articles

References

    1. Palsson T. G.; Gilliam-Vigh H.; Jensen B. A.H.; Jeppesen P. B.; Lund A. B.; Knop F. K.; Nielsen C. K. Targeting the GLP-2 receptor in the management of obesity. Peptides 2024, 177, 171210.10.1016/j.peptides.2024.171210. - DOI - PubMed
    1. Ansari S.; Khoo B.; Tan T. Targeting the incretin system in obesity and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2024, 20, 447–459. 10.1038/s41574-024-00979-9. - DOI - PubMed
    1. Aksu H.; Demirbilek A.; Uba A. I. Insights into the structure and activation mechanism of some class B1 GPCR family members. Mol. Biol. Rep. 2024, 51, 966.10.1007/s11033-024-09876-w. - DOI - PubMed

Publication types

LinkOut - more resources